{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:46:04Z","timestamp":1794591964282,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013087, 2016049, 2017025, 2018075, and 2020088"],"award-info":[{"award-number":["2013087, 2016049, 2017025, 2018075, and 2020088"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013087, 2016049, 2017025, 2018075, and 2020088"],"award-info":[{"award-number":["2013087, 2016049, 2017025, 2018075, and 2020088"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013087, 2016049, 2017025, 2018075, and 2020088"],"award-info":[{"award-number":["2013087, 2016049, 2017025, 2018075, and 2020088"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013087, 2016049, 2017025, 2018075, and 2020088"],"award-info":[{"award-number":["2013087, 2016049, 2017025, 2018075, and 2020088"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anabolic\u2013androgenic steroids (AAS) are commonly taken to increase muscle size and enhance performance. However, AAS can lead to many adverse effects, including challenges with mental health and behavior. This study aims to identify behavioral and psychological correlates of AAS use, and explore associations with dependence symptoms among female weightlifters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A sample of\n                      <jats:italic>n<\/jats:italic>\n                      \u2009= 32 female weightlifters, including 16 with reported AAS use completed questionnaires including the Achenbach System of Empirically Based Assessment (ASEBA) and Buss-Perry Aggression Questionnaire (BPAQ). AAS dependence was evaluated using the Structure Clinical Interview for DSM-IV. Group comparisons were made using Welch\u2019s t-tests between control and AAS groups, and AAS dependent and non-dependent groups. Exploratory correlation analyses were computed between symptoms of dependence and behavioral and psychiatric scales.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Females who had used AAS had higher levels of both externalizing and internalizing psychopathology, including antisocial and attention problems, as well as aggressive traits. The most prevalent dependence symptoms were time spent on activities surrounding AAS use (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009= 7, 50%), and using more or for longer than planned (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009= 6, 42.9%). Dependence symptoms were associated with several ASEBA scales: tolerance was correlated with aggressive behavior (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009= 0.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001), withdrawal was correlated with attention problems (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009= 0.78,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001), and being unable to quit use was associated with anxious\/depressive (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009= 0.80,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001) and internalizing problems (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009= 0.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Females who currently or previously used AAS demonstrated significantly more difficulties with maladaptive functioning and aggressive traits compared to those who have never used. Attention problems and aggressive behavior were also associated with symptoms of AAS dependence, though longitudinal studies are required to determine the direction of this relationship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-025-03711-5","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:57:22Z","timestamp":1746406642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Psychological traits associated with anabolic androgenic steroid use and dependence: an exploratory cross-sectional study among female athletes"],"prefix":"10.1186","volume":"25","author":[{"given":"Morgan","family":"Scarth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Amalia","family":"Havnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Lindvik","family":"J\u00f8rstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Bj\u00f8rnebekk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"5","key":"3711_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383\u201398.","journal-title":"Ann Epidemiol"},{"key":"3711_CR2","first-page":"117822182090415","volume":"14","author":"IA Havnes","year":"2020","unstructured":"Havnes IA, J\u00f8rstad ML, McVeigh J, Van Hout MC, Bj\u00f8rnebekk A. The anabolic androgenic steroid treatment gap: a national study of substance use disorder treatment. Subst Abuse. 2020;14:1178221820904150.","journal-title":"Subst Abuse"},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.drugalcdep.2020.108255","volume":"217","author":"IA Havnes","year":"2020","unstructured":"Havnes IA, Bukten A, Rognli EB, Muller AE. Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study. Drug Alcohol Depend. 2020;217:108255.","journal-title":"Drug Alcohol Depend"},{"key":"3711_CR4","doi-asserted-by":"crossref","unstructured":"Piatkowski T, Whiteside B, Robertson J, Henning A, Lau EHY, Dunn M. What is the prevalence of anabolic-androgenic steroid use among women? A systematic review. Addiction. 2024;119(12):2088\u2013100.","DOI":"10.1111\/add.16643"},{"issue":"8","key":"3711_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/1359105316639436","volume":"23","author":"M Tiggemann","year":"2018","unstructured":"Tiggemann M, Zaccardo M. \u2018Strong is the new skinny\u2019: a content analysis of# fitspiration images on Instagram. J Health Psychol. 2018;23(8):1003\u201311.","journal-title":"J Health Psychol"},{"key":"3711_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bodyim.2020.09.002","volume":"35","author":"CL Donovan","year":"2020","unstructured":"Donovan CL, Uhlmann LR, Loxton NJ. Strong is the new skinny, but is it ideal?: A test of the tripartite influence model using a new measure of fit-ideal internalisation. Body Image. 2020;35:171\u201380.","journal-title":"Body Image"},{"key":"3711_CR7","doi-asserted-by":"crossref","unstructured":"Schneider KE, Webb L, Boon D, Johnson RM. Adolescent anabolic-androgenic steroid use in association with other drug use, injection drug use, and team sport participation. J Child Adolesc Subst Abuse. 2020;29(4-6):246\u201351.","DOI":"10.1080\/1067828X.2022.2052219"},{"issue":"1","key":"3711_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-016-0056-3","volume":"11","author":"A B\u00f6rjesson","year":"2016","unstructured":"B\u00f6rjesson A, G\u00e5revik N, Dahl M-L, Rane A, Ekstr\u00f6m L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abuse Treat Prev Policy. 2016;11(1):1\u20136.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"3711_CR9","doi-asserted-by":"crossref","unstructured":"Havnes IA, J\u00f8rstad ML, Innerdal I, Bj\u00f8rnebekk A. Anabolic-androgenic steroid use among women\u2013A qualitative study on experiences of masculinizing, gonadal and sexual effects. Int J Drug Policy. 2020;95:102876.","DOI":"10.1016\/j.drugpo.2020.102876"},{"issue":"1","key":"3711_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12954-023-00786-x","volume":"20","author":"T Piatkowski","year":"2023","unstructured":"Piatkowski T, Robertson J, Lamon S, Dunn M. Gendered perspectives on women\u2019s anabolic\u2013androgenic steroid (AAS) usage practices. Harm Reduct J. 2023;20(1):56.","journal-title":"Harm Reduct J"},{"issue":"11","key":"3711_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jsams.2023.08.179","volume":"26","author":"M Dunn","year":"2023","unstructured":"Dunn M, Piatkowski TM, Robertson J, Lamon S. Is the use of performance and image enhancing drugs (PIEDs) in women an issue of concern? The findings from a stakeholder consultation. J Sci Med Sport. 2023;26(11):574\u20139.","journal-title":"J Sci Med Sport"},{"issue":"8","key":"3711_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1592\/phco.31.8.757","volume":"31","author":"EJ Ip","year":"2011","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011;31(8):757\u201366.","journal-title":"Pharmacotherapy."},{"issue":"3","key":"3711_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/joim.12850","volume":"285","author":"H Horwitz","year":"2019","unstructured":"Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333\u201340.","journal-title":"J Intern Med"},{"issue":"2","key":"3711_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10286-017-0470-2","volume":"28","author":"O Barbosa Neto","year":"2018","unstructured":"Barbosa Neto O, da Mota GR, De Sordi CC, Resende E, Resende L, da Vieira Silva MA, et al. Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities. Clin Auton Res. 2018;28(2):231\u201344.","journal-title":"Clin Auton Res"},{"key":"3711_CR15","doi-asserted-by":"publisher","first-page":"108604","DOI":"10.1016\/j.drugalcdep.2021.108604","volume":"221","author":"LE Hauger","year":"2021","unstructured":"Hauger LE, Havnes IA, J\u00f8rstad ML, Bj\u00f8rnebekk A. Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 2021;221:108604.","journal-title":"Drug Alcohol Depend"},{"key":"3711_CR16","doi-asserted-by":"crossref","unstructured":"Chegeni R, Pallesen S, McVeigh J, Sagoe D. Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies. Psychopharmacology. 2021;238:1911\u201322.","DOI":"10.1007\/s00213-021-05818-7"},{"issue":"5","key":"3711_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1403494820973096","volume":"49","author":"S Gestsdottir","year":"2021","unstructured":"Gestsdottir S, Kristjansdottir H, Sigurdsson H, Sigfusdottir ID. Prevalence, mental health and substance use of anabolic steroid users: a population-based study on young individuals. Scand J Public Health. 2021;49(5):555\u201362.","journal-title":"Scand J Public Health"},{"issue":"6","key":"3711_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","volume":"20","author":"EJ Ip","year":"2010","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20(6):475\u201381.","journal-title":"Clin J Sport Med"},{"key":"3711_CR19","doi-asserted-by":"publisher","first-page":"109275","DOI":"10.1016\/j.drugalcdep.2022.109275","volume":"231","author":"M Scarth","year":"2022","unstructured":"Scarth M, Havnes IA, J\u00f8rstad ML, McVeigh J, Van Hout MC, Westlye LT, et al. Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway. Drug Alcohol Depend. 2022;231:109275.","journal-title":"Drug Alcohol Depend"},{"key":"3711_CR20","doi-asserted-by":"publisher","first-page":"107874","DOI":"10.1016\/j.drugalcdep.2020.107874","volume":"208","author":"LE Hauger","year":"2020","unstructured":"Hauger LE, Westlye LT, Bj\u00f8rnebekk A. Anabolic androgenic steroid dependence is associated with executive dysfunction. Drug Alcohol Depend. 2020;208:107874.","journal-title":"Drug Alcohol Depend"},{"key":"3711_CR21","doi-asserted-by":"crossref","unstructured":"Bj\u00f8rnebekk A, Kaufmann T, Hauger LE, Klonteig S, Hullstein IR, Westlye LT. Long-term anabolic androgenic steroid use is associated with deviant brain aging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(5):579\u201389.","DOI":"10.1016\/j.bpsc.2021.01.001"},{"issue":"4","key":"3711_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","volume":"82","author":"A Bj\u00f8rnebekk","year":"2017","unstructured":"Bj\u00f8rnebekk A, Walhovd KB, J\u00f8rstad ML, Due-T\u00f8nnessen P, Hullstein IR, Fjell AM. Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters. Biol Psychiatry. 2017;82(4):294\u2013302.","journal-title":"Biol Psychiatry"},{"key":"3711_CR23","doi-asserted-by":"publisher","first-page":"e3040","DOI":"10.1002\/brb3.3040","volume":"13","author":"ML J\u00f8rstad","year":"2023","unstructured":"J\u00f8rstad ML, Scarth M, Torgersen S, Pope HG, Bj\u00f8rnebekk A. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters. Brain Behav. 2023;13:e3040.","journal-title":"Brain Behav."},{"issue":"1\u20133","key":"3711_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugalcdep.2012.11.008","volume":"130","author":"G Kanayama","year":"2013","unstructured":"Kanayama G, Kean J, Hudson JI, Pope HG Jr. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130(1\u20133):208\u201314.","journal-title":"Drug Alcohol Depend"},{"key":"3711_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpsychires.2022.09.023","volume":"155","author":"M Scarth","year":"2022","unstructured":"Scarth M, J\u00f8rstad ML, Reierstad A, Klonteig S, Torgersen S, Hullstein IR, et al. Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway. J Psychiatr Res. 2022;155:295\u2013301.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"3711_CR26","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s00213-020-05603-y","volume":"237","author":"A Vaskinn","year":"2020","unstructured":"Vaskinn A, Hauger LE, Bj\u00f8rnebekk A. Theory of mind in users of anabolic androgenic steroids. Psychopharmacology. 2020;237(10):3191\u20139.","journal-title":"Psychopharmacology"},{"issue":"2","key":"3711_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.yhbeh.2014.04.008","volume":"66","author":"MM Onakomaiya","year":"2014","unstructured":"Onakomaiya MM, Porter DM, Oberlander JG, Henderson LP. Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse. Horm Behav. 2014;66(2):283\u201397.","journal-title":"Horm Behav"},{"issue":"10","key":"3711_CR28","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/j.1875-9114.2012.01123","volume":"32","author":"EJ Ip","year":"2012","unstructured":"Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012;32(10):910\u20139.","journal-title":"Pharmacotherapy."},{"issue":"6","key":"3711_CR29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1176\/appi.ajp.2009.08111699","volume":"166","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009;166(6):642\u20135.","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"3711_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.02.008","volume":"102","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Hudson JI, Pope HG Jr. Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009;102(1\u20133):130\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"3711_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","volume":"23","author":"HG Pope Jr","year":"2014","unstructured":"Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014;23(4):371\u20137.","journal-title":"Am J Addict"},{"issue":"8","key":"3711_CR32","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/add.14629","volume":"114","author":"LE Hauger","year":"2019","unstructured":"Hauger LE, Westlye LT, Fjell AM, Walhovd KB, Bj\u00f8rnebekk A. Structural brain characteristics of anabolic-androgenic steroid dependence in men. Addiction. 2019;114(8):1405\u201315.","journal-title":"Addiction"},{"issue":"1","key":"3711_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbr.2004.02.010","volume":"154","author":"JL Triemstra","year":"2004","unstructured":"Triemstra JL, Wood RI. Testosterone self-administration in female hamsters. Behav Brain Res. 2004;154(1):221\u20139.","journal-title":"Behav Brain Res"},{"issue":"4","key":"3711_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.yfrne.2007.12.002","volume":"29","author":"RI Wood","year":"2008","unstructured":"Wood RI. Anabolic\u2013androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol. 2008;29(4):490\u2013506.","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"3711_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2011.12.007","volume":"122","author":"OK van Emmerik-van","year":"2012","unstructured":"van Emmerik-van OK, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1):11\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"19","key":"3711_CR36","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1001\/jama.1985.03350430083032","volume":"253","author":"RH Strauss","year":"1985","unstructured":"Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. JAMA. 1985;253(19):2871\u20133.","journal-title":"JAMA"},{"issue":"1","key":"3711_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000012362","volume":"69","author":"AJ Gruber","year":"2000","unstructured":"Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000;69(1):19\u201326.","journal-title":"Psychother Psychosom"},{"issue":"11","key":"3711_CR38","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1080\/10826080500222727","volume":"40","author":"KE Miller","year":"2005","unstructured":"Miller KE, Hoffman JH, Barnes GM, Sabo D, Melnick MJ, Farrell MP. Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors. Subst Use Misuse. 2005;40(11):1637\u201357.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"3711_CR39","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/dta.3230","volume":"14","author":"JX Amaral","year":"2022","unstructured":"Amaral JX, Deslandes AC, Padilha MC, Vieira Neto L, Osorio LE, Aquino Neto FR, et al. No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders. Drug Test Anal. 2022;14(6):1079\u201388.","journal-title":"Drug Test Anal"},{"key":"3711_CR40","doi-asserted-by":"publisher","first-page":"629428","DOI":"10.3389\/fpsyt.2021.629428","volume":"12","author":"R Chegeni","year":"2021","unstructured":"Chegeni R, Notelaers G, Pallesen S, Sagoe D. Aggression and psychological distress in male and female anabolic-androgenic steroid users: a multigroup latent class analysis. Front Psychiatry. 2021;12:629428.","journal-title":"Front Psychiatry"},{"issue":"4","key":"3711_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00213-015-4193-6","volume":"233","author":"MM Onakomaiya","year":"2016","unstructured":"Onakomaiya MM, Henderson LP. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology. 2016;233(4):549\u201369.","journal-title":"Psychopharmacology"},{"key":"3711_CR42","volume-title":"Manual for the ASEBA adult forms & profiles","author":"TM Achenbach","year":"2003","unstructured":"Achenbach TM, Rescorla L. Manual for the ASEBA adult forms & profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth; 2003."},{"issue":"3","key":"3711_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","volume":"63","author":"AH Buss","year":"1992","unstructured":"Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63(3):452.","journal-title":"J Pers Soc Psychol"},{"issue":"3","key":"3711_CR44","doi-asserted-by":"publisher","first-page":"100198","DOI":"10.1016\/j.peh.2021.100198","volume":"9","author":"IA Havnes","year":"2021","unstructured":"Havnes IA, J\u00f8rstad ML, Bj\u00f8rnebekk A. Double trouble? A mixed methods study exploring experiences with combined use of anabolic-androgenic steroids and psychoactive substances among women. Perform Enhanc Health. 2021;9(3):100198.","journal-title":"Perform Enhanc Health"},{"key":"3711_CR45","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Academic Press; 1988.","edition":"2"},{"issue":"1","key":"3711_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"1","key":"3711_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12888-023-04781-1","volume":"23","author":"M Scarth","year":"2023","unstructured":"Scarth M, Westlye LT, Havnes IA, Bj\u00f8rnebekk A. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters. BMC Psychiatry. 2023;23(1):342.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"3711_CR48","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/2167479519896326","volume":"9","author":"A Henning","year":"2021","unstructured":"Henning A, Andreasson J. \u201cYay, Another Lady Starting a Log!\u201d: Women\u2019s Fitness Doping and the Gendered Space of an Online Doping Forum. Commun Sport. 2021;9(6):988\u20131007.","journal-title":"Commun Sport"},{"issue":"2","key":"3711_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/00914509241256002","volume":"51","author":"T Piatkowski","year":"2024","unstructured":"Piatkowski T, Whiteside B, Robertson J, Lamon S, Dunn M. Performance and image enhancing drug use among australian women: the role of interpersonal relationships in facilitating use. Contemp Drug Probl. 2024;51(2):142\u201359.","journal-title":"Contemp Drug Probl"},{"issue":"1","key":"3711_CR50","doi-asserted-by":"publisher","first-page":"9479","DOI":"10.1038\/s41598-022-12977-w","volume":"12","author":"E Kildal","year":"2022","unstructured":"Kildal E, Hassel B, Bj\u00f8rnebekk A. ADHD symptoms and use of anabolic androgenic steroids among male weightlifters. Sci Rep. 2022;12(1):9479.","journal-title":"Sci Rep"},{"issue":"3","key":"3711_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biopsych.2011.06.024","volume":"71","author":"HG Pope Jr","year":"2012","unstructured":"Pope HG Jr, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012;71(3):254\u201361.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"3711_CR52","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1177\/1087054715626511","volume":"23","author":"AJ Capusan","year":"2019","unstructured":"Capusan AJ, Bendtsen P, Marteinsdottir I, Larsson H. Comorbidity of adult ADHD and its subtypes with substance use disorder in a large population-based epidemiological study. J Atten Disord. 2019;23(12):1416\u201326.","journal-title":"J Atten Disord"},{"issue":"2","key":"3711_CR53","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.peh.2023.100248","volume":"11","author":"T Piatkowski","year":"2023","unstructured":"Piatkowski T, Robertson J, Dunn M. Polysubstance use practices among women using anabolic-androgenic steroids (AAS). Perform Enhanc Health. 2023;11(2):100248.","journal-title":"Perform Enhanc Health"},{"issue":"6","key":"3711_CR54","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpedi.161.6.572","volume":"161","author":"DL Elliot","year":"2007","unstructured":"Elliot DL, Cheong J, Moe EL, Goldberg L. Cross-sectional study of female students reporting anabolic steroid use. Arch Pediatr Adolesc Med. 2007;161(6):572\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"3711_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1087054718821728","volume":"25","author":"SM Sodano","year":"2021","unstructured":"Sodano SM, Tamulonis JP, Fabiano GA, Caserta AM, Hulme KF, Hulme KL, et al. Interpersonal problems of young adults with and without attention-deficit\/hyperactivity disorder. J Atten Disord. 2021;25(4):562\u201371.","journal-title":"J Atten Disord"},{"issue":"7","key":"3711_CR56","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1037\/bul0000101","volume":"143","author":"S Wilson","year":"2017","unstructured":"Wilson S, Stroud CB, Durbin CE. Interpersonal dysfunction in personality disorders: a meta-analytic review. Psychol Bull. 2017;143(7):677.","journal-title":"Psychol Bull"},{"key":"3711_CR57","doi-asserted-by":"publisher","first-page":"104644","DOI":"10.1016\/j.yhbeh.2019.104644","volume":"123","author":"SN Geniole","year":"2020","unstructured":"Geniole SN, Bird BM, McVittie JS, Purcell RB, Archer J, Carre JM. Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression. Horm Behav. 2020;123:104644.","journal-title":"Horm Behav"},{"key":"3711_CR58","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.neuropharm.2018.11.039","volume":"156","author":"LE Been","year":"2019","unstructured":"Been LE, Gibbons AB, Meisel RL. Towards a neurobiology of female aggression. Neuropharmacology. 2019;156:107451.","journal-title":"Neuropharmacology"},{"key":"3711_CR59","doi-asserted-by":"crossref","unstructured":"Sullivan MA. Drug use and mental health: comorbidity between substance use and psychiatric disorders. Substance and Non-Substance Related Addictions: A Global Approach. 2022:3\u201317.","DOI":"10.1007\/978-3-030-84834-7_1"},{"issue":"7","key":"3711_CR60","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1469-7610.2007.01733.x","volume":"48","author":"MK Nock","year":"2007","unstructured":"Nock MK, Kazdin AE, Hiripi E, Kessler RC. Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication. J Child Psychol Psychiatry. 2007;48(7):703\u201313.","journal-title":"J Child Psychol Psychiatry"},{"key":"3711_CR61","doi-asserted-by":"publisher","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","volume":"238","author":"T Santo Jr","year":"2022","unstructured":"Santo T Jr, Campbell G, Gisev N, Martino-Burke D, Wilson J, Colledge-Frisby S, et al. Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 2022;238:109551.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3711_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1087054711416909","volume":"16","author":"NL Nussbaum","year":"2012","unstructured":"Nussbaum NL. ADHD and female specific concerns: a review of the literature and clinical implications. J Atten Disord. 2012;16(2):87\u2013100.","journal-title":"J Atten Disord"},{"issue":"1\u20132","key":"3711_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.psychres.2014.03.006","volume":"217","author":"P Prada","year":"2014","unstructured":"Prada P, Hasler R, Baud P, Bednarz G, Ardu S, Krejci I, et al. Distinguishing borderline personality disorder from adult attention deficit\/hyperactivity disorder: a clinical and dimensional perspective. Psychiatry Res. 2014;217(1\u20132):107\u201314.","journal-title":"Psychiatry Res"},{"issue":"6","key":"3711_CR64","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/dar.12249","volume":"34","author":"JT Young","year":"2015","unstructured":"Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, et al. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug Alcohol Rev. 2015;34(6):683\u201393.","journal-title":"Drug Alcohol Rev"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03711-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T02:02:39Z","timestamp":1746410559000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03711-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03711-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3263082\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics South East Norway (approval #2013\/601). Participants received a written description of the study prior to participation and provided formal informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}